Phase 1 Study Accessing the Safety and Tolerability of CBP-307

Clinical trial NCT02280434 · COMPLETED

Trial details

NCT number: NCT02280434
Sponsor: Connect Biopharm LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2014-11-01
Primary completion: 2015-08-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.